endocrinemer.pre

94
ENDOCRINE EMERGENCIES Jim Holliman, M.D., F.A.C.E.P. Professor of Military and Emergency Medicine Uniformed Services University of the Health Sciences Clinical Professor of Emergency Medicine George Washington University Bethesda, Maryland, U.S.A.

Upload: amiroh-kurniati

Post on 22-Oct-2014

67 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Endocrinemer.pre

ENDOCRINE EMERGENCIES

Jim Holliman, M.D., F.A.C.E.P.Professor of Military and Emergency Medicine

Uniformed Services University of the Health SciencesClinical Professor of Emergency Medicine

George Washington UniversityBethesda, Maryland, U.S.A.

Page 2: Endocrinemer.pre
Page 3: Endocrinemer.pre

Endocrine Emergencies

Adrenal–Addisonian Crisis–Pheochromocytoma

Thyroid–Thyroid Storm–Myxedema Coma

Miscellaneous–Hypoglycemia –Diabetes Insipidus

Page 4: Endocrinemer.pre

General Mechanisms of Endocrine Pathophysiology

Deficient hormone actionExcess hormone production or actionNeoplasia

Page 5: Endocrinemer.pre

Mechanisms of Endocrine Pathophysiology

1. Deficient hormone action–Primary glandular failure

ƒ Congenitalƒ Acquired (atrophy, surgery, tumor, drug-induced, autoimmune, infectious)

–Secondary glandular failure–Disordered hormone release or activation–Accelerated hormone metabolism–Target tissue resistance

Page 6: Endocrinemer.pre

Mechanisms of Endocrine Pathophysiology (cont.)

2. Excess hormone production or action–Gland autonomy (neoplasia, hyperplasia)–Abnormal stimulation–Ectopic hormone production–Altered hormone metabolism–Target tissue increased sensitivity to hormone action

Page 7: Endocrinemer.pre

Mechanisms of Endocrine Pathophysiology (cont.)

3. Neoplasia–Benign vs. malignant–Functional vs. nonfunctional–Ectopic hormone production–Sporadic vs. familial syndromes

Page 8: Endocrinemer.pre

Multiple Endocrine Neoplasia (MEN) Syndromes

MEN I (Wermer)–Hyperparathyroid, pituitary adenoma, pancreatic cancer

MEN IIa (Sipple)–Hyperparathyroid, thyroid medullary ca, pheochromocytoma

MEN IIb (or III)–Medullary thyroid ca, pheochromocytoma, mucosal neuromas, Marfinoid habitus

Page 9: Endocrinemer.pre

Polyendocrine Failure Syndromes

Type I–Hypoparathyroidism–Hypoadrenalism–Mucocutaneous candidiasis–Other (hypogonadism,autoimmune thyroid disease, JODM)

Type II–Adrenal insufficiency–Autoimmune thyroid disease–Other (JODM, primary or secondary gonadal failure)

Page 10: Endocrinemer.pre

Diseases of the Adrenals

Adrenocortical insufficiency–Addison's–Hypopituitarism–Iatrogenic ACTH deficiency

Cushing's Syndrome–Cushing's Disease (cortical hyperplasia)–Pituitary tumor

Adrenal adenoma or carcinoma–Ectopic ACTH syndrome (from tumors)

Virilization–Adrenal adenoma or carcinoma–Congenital adrenal hyperplasia (CAH)

Adrenal-mediated hypertension syndromes–Primary hyperaldosteronism (adenoma vs. hyperplasia), Cushing's syndrome, Pheochromocytomas

Page 11: Endocrinemer.pre
Page 12: Endocrinemer.pre

Etiologies of Primary Adrenal Insufficiency

Iatrogenic suppressionAutoimmune adrenalitis (idiopathic)Infections (mycobacteria, fungal, CMV, HIV)SarcoidosisHemorrhage (anticoagulants, meningococcemia,

trauma, toxemia, emboli)Collagen vascular diseaseAmyloidosisHemochromatosisMetastatic malignancyCongenital (hypoplasia, adrenogenital syndrome,

adrenoleucodystrophy)

Page 13: Endocrinemer.pre

CT scan showing bilateral adrenal hemorrhages in a 57 year old female with breast cancer

Page 14: Endocrinemer.pre

Etiologies of Secondary Adrenal Insufficiency

Pituitary insufficiency–Congenital, tumor, infarction, sarcoid, autoimmune

Hypothalamic dysfunction–Tumor–Vascular malformation

Page 15: Endocrinemer.pre

Symptoms of Adrenal Insufficiency

Weakness, fatigue, lethargyNausea, vomiting+/- diarrheaAnorexia, weight lossMental sluggishness+/- syncopeAddisonian Crisis:

–Shock–Cardiovascular collapse

Page 16: Endocrinemer.pre

Signs of Adrenal Insufficiency

Hypotension Other signs of dehydrationHyperpigmentation / vitiligoSkin atrophy Muscle wastingLoss of axillary & pubic hair+/- fever

Page 17: Endocrinemer.pre

Lab Findings in Adrenal Insufficiency

HyponatremiaHyperkalemiaHypoglycemiaAzotemia (prerenal)+/- eosinophilia+/- anemia

Page 18: Endocrinemer.pre

Precipitating Factors for Addisonian Crisis

Acute infection, esp. pneumoniaAcute MIPulmonary embolusTrauma / burnsSurgery Heat exposureVomiting / diarrheaDehydrationBlood lossRapid cessation or reduction of chronic steroid

therapy

Page 19: Endocrinemer.pre

Acute Adrenal CrisisCaveats

Suspect this dx when:–Sudden hypotension in response to procedure or stress, and does not correct with initial IV fluids +/- raising legs

Patients previously maintained on chronic glucocorticoid Rx may not exhibit severe dehydration or hypotension until preterminal since mineralocorticoid function is usually maintained

Page 20: Endocrinemer.pre

Addisonian Crisis Rx

High flow oxygenAggressive fluid / electrolyte replacement

–Initially NS - usually need 4 to 6 liters–Switch to LR when K+ decreases

IV hydrocortisone–100 to 250 mg IV bolus–10 to 20 mg per hr. IV infusion

+/- cortisone acetate 50 mg IM (in case infusion stops)

Search for precipitating cause

Page 21: Endocrinemer.pre

Further Rx of Addisonian Crisis

Once the patient's condition improves:–Decrease hydrocortisone to 100 mg bid–Halve dose daily till maintenance dose achieved (usually 20 mg hydrocortisone per day)–Add fludrocortisone 0.1 mg per day when dose of cortisone < 100 mg / day

Page 22: Endocrinemer.pre

Prevention of Acute Adrenal Crisis

For patients on chronic steroid Rx:–Double their normal daily dose before and for at least 2 - 3 days after a stressful procedure or when an active infection is present

For severe stress:–Consider tripling steroid dose

Page 23: Endocrinemer.pre

Dosing Comparisons for Adrenocortical Steroids

STEROID t1/2 (hrs.) Relative potency

Equivalent doseCortisone 8 - 12 0.8 25

Cortisol 8 - 12 1.0 20

Prednisone 12 - 36 4.0 5

Methylpred- nisolone

12 - 36 5.0 4

Dexameth- asone

36 - 72 25 0.75

Page 24: Endocrinemer.pre

Pheochromocytoma

Tumor of chromaffin cellsChromaffin cells produce, store, &

secrete catecholaminesClinical features of these tumors are due

to excessive catechol release ( not usually due to direct tissue extension effects of tumor)

Cause only 0.1% of cases of hypertension but represent a curable cause of hypertension

Page 25: Endocrinemer.pre

Excised pheochromocytoma (left slice chromium stained)

Page 26: Endocrinemer.pre

Excised pheochromocytoma

Page 27: Endocrinemer.pre

High power microscopy view of stained pheochromocytoma cells

Page 28: Endocrinemer.pre

Familial Syndromes Associated with Pheochromocytomas

Most are autosomal dominant (variable penetration)MEN II (Sipple Syndrome)

–Pheos in > 75 % of casesMEN III (mucosal neuroma syndrome)

–Pheos in > 75 %Von Recklinghausen's neurofibromatosis

–Pheos in 1 %Von Hippel - Lindau Disease

–Pheos in 5 to 10 %

Page 29: Endocrinemer.pre

Pheochromocytoma Locations

Adrenal medulla : 90 %Abdomen : 8 %Neck or thorax : 2 %Multiple sites : 10 %Malignant : 10 %Associated with familial syndromes : 5 %

Page 30: Endocrinemer.pre

Pheochromocytoma Catechol Secretion

Most secrete both norepi and epi (generally norepi > epi)

Most extrarenal tumors secrete only norepi

Malignant tumors secrete more dopamine and HVA

Predominant catechol secreted cannot be predicted by clinical presentation

Page 31: Endocrinemer.pre
Page 32: Endocrinemer.pre
Page 33: Endocrinemer.pre

Most Common Symptoms of Pheochromocytoma

Hypertension > 90 %–Sustained 30 %–Sustained with crises 30 %–Paroxysmal 30 %

Headache 80 %Sweating 70 %Palpitations 65 %

Page 34: Endocrinemer.pre

Additional Symptoms of Pheochromocytoma

Pallor 45 %Nausea +/- emesis 40 %Nervousness 35 %Fundoscopic changes 30 %Weight loss 25 %Epigastric or chest pain 20 %

Page 35: Endocrinemer.pre

Indications to Screen Patients for Pheos

Hypertension with:–Grade 3 or 4 retinopathy of uncertain cause–Weight loss–Hyperglycemia–Hypermetabolism with nl. thyroid profile–Cardiomyopathy–Resistance to 2 or 3 drug Rx–Orthostatic hypotension (not due to drug Rx)–Unexplained fever

Marked hyperlability of BPRecurrent attacks of sx of pheos

Page 36: Endocrinemer.pre

More Indications to Screen Patients for Pheos

Severe pressor response during or induced by:–Anesthesia or intubation–Surgery –Angiography–Parturition

Unexplained circulatory shock during:–Anesthesia–Pregnancy, delivery, or puerperium–Surgery (or after surgery)–Use of phenothiazines

Family history of pheosHyperlabile BP or severe hypertension with pregnancyX ray evidence of suprarenal mass

Page 37: Endocrinemer.pre

Conditions Causing Increased Urinary Catechol Levels

HypoglycemiaSurgeryCHFAcute MICirculatory shockSepsis AcidosisIncreased ICPSpinal cord injuryTrauma / burnsParturitionDelerium tremensStrenuous exercise

Page 38: Endocrinemer.pre

Conditions Causing Decreased Urinary Catechol Levels

Renal insufficiency (oliguria)MalnutritionQuadriplegiaOrthostatic hypotension due to

adrenergic insufficiency

Page 39: Endocrinemer.pre

Localization Techniques for Pheos

Abdominal CT : most useful–Cannot confirm tissue dx

Iodine 131 metaiodobenzylguanidine nuclear medicine scanning–Helpful for non-abdominal tumors and to confirm function

Angiography–Requires medication prep for safety

Page 40: Endocrinemer.pre

Bilateral pheochromocytomas (the one on the left has a small area of central hemorrhage)

Page 41: Endocrinemer.pre

6 cm cystic pheo in the right adrenal of a 29 year old female

Page 42: Endocrinemer.pre

Pheochromocytoma at the level of the 7th rib

Page 43: Endocrinemer.pre
Page 44: Endocrinemer.pre
Page 45: Endocrinemer.pre
Page 46: Endocrinemer.pre
Page 47: Endocrinemer.pre
Page 48: Endocrinemer.pre

Intramyocardial pheo in a patient (who died of CHF from effects of the pheo) known to have a pheo but who never underwent radionuclide scanning to localize it

Page 49: Endocrinemer.pre

Meds for Acute Symptom Control for Pheos (also for pre-angio or preop prep)

Phentolamine 2 to 5 mg IV (alpha block)Then propranolol 1 to 2 mg IV (beta block) or

labetolol 20 to 40 mg IV (alpha & beta block)Use nitroprusside or phentolamine infusion for

hypertensive crisis (50 to 100 mg in 250 cc D5W)For hypotension : norepi infusionFor arrhythmias : lidocaine bolus & infusion

Page 50: Endocrinemer.pre

Meds for Nonemergent or Chronic Sx Control for Pheos

Phenoxybenzamine 10 to 20 mg tid-qid (alpha block)

Prazosin 1 to 5 mg bidPropranolol 10 to 40 mg qid or labetolol

200 to 600 mg bid (beta block)Alpha-methyl-p-tyrosine (metyrosine)

250 mg to 1 gram bid (synthesis inhibitor)

Page 51: Endocrinemer.pre

Workup scheme for pheos

Page 52: Endocrinemer.pre

Thyroid Storm Definitions

"Exaggerated or florid state of thyrotoxicosis"Life threatening, sudden onset of thyroid

hyperactivity"May represent end stage of the continuum:

–hyperthyroidism to thyrotoxicosis to thyrotoxic crisis to thyroid storm

"Probably reflects the addition of adrenergic hyperactivity, induced by a nonspecific stress, into

the setting of untreated or undertreated hyperthyroidism"

Page 53: Endocrinemer.pre

Thyroid Storm Epidemiology

Most cases secondary to toxic diffuse goiter (Grave's Disease)–Mostly in women in 3rd to 4th decades

Some cases due to toxic multinodular goiter–Mostly in women in 4th to 7th decades

Very rarely due to :–Factitious–Thyroiditis–Malignancies

Very rare in children

Page 54: Endocrinemer.pre

51 year old male with Graves Disease who presented with urine retention

Page 55: Endocrinemer.pre

Pretibial myxedema and square toes in the same patient on the prior slide

Page 56: Endocrinemer.pre

Lag ophthalmos in a patient with Graves Disease

Page 57: Endocrinemer.pre

Another patient with Graves Disease

Page 58: Endocrinemer.pre

Thyroid scan of patient with Graves Disease

Scan of patient with toxic multinodular goiter with hot nodule

Page 59: Endocrinemer.pre

Thyroid Storm Prognosis

Old references quote almost 100% mortality untreated and 20% mortality treated ( but before beta blockers)

Current mortality ? < 5 % treated (although not well studied or reported due to rarity of cases)

Page 60: Endocrinemer.pre

Thyroid Storm Clinical Presentation

Most important:–Fever–Abnormal mental status (agitation confusion, coma)

TachycardiaVomiting / diarrhea+/- jaundice+/- goiter+/- exopthalmos

Page 61: Endocrinemer.pre

Thyroid Storm CNS Manifestations

With increasing severity of storm:–Hyperkinesis–Restlessness–Emotional lability–Confusion–Psychosis–Apathy–Somnolence–Obtundation–Coma

Page 62: Endocrinemer.pre

Thyroid Storm Cardiovascular Manifestations

Increased heart rate–Sinus tach or atrial fib

Increased irritability–First degree AV block, PVC's, PAC's

Wide pulse pressureApical systolic murmurLoud S1, S2May develop CHF

Page 63: Endocrinemer.pre

"Apathetic" or "Nonactivated" Thyrotoxicosis

Represents dangerous hyperthyroidism masked by preexistent sx

Usually age > 70Recent weight loss > 40 lbs.May present as seemingly isolated sx:

–CHF–Atrial fib–CNS sx

ƒ Somnolence, apathy, coma

Page 64: Endocrinemer.pre

Thyroid Storm Precipitating Factors

Infection, esp. pneumoniaCVACHFPulmonary embolusDKAParturition / toxemiaTraumaSurgeryI 131 RxIodinated contrast agentsWithdrawl of antithyroid drugs

Page 65: Endocrinemer.pre

Thyroid Storm Initial Lab Studies Needed

CBC, lytes, BUN, glucoseT4, T3, T3 RU, TSHU/AABG+/- LFT's+/- serum cortisol

Page 66: Endocrinemer.pre

Thyroid Storm Usual Lab Results

Lab studies do NOT distinguish thyrotoxicosis from thyroid storm

Usually T4 & T3 elevated, but may be only increased T3

Usually plasma cortisol low for degree of physiologic stress present

Hyperglycemia common

Page 67: Endocrinemer.pre

Thyroid Storm Emergent Rx

High flow O2Rapid cooling if markedly hyperthermic

–Ice packs, cooling blanket, mist / fans, NG lavage, acetominophen (ASA contraindicated)

IV +/- IV fluid bolus if dehydrated–May need inotropes if already have CHF)

Propranolol 1 to 2 mg IV & repeat or labetolol 20 to 40 mg IV & repeat prn

+/- digoxin, Ca channel blockers for rate control for atrial fib; +/- diuretics for CHF

Find & treat precipitating cause

Page 68: Endocrinemer.pre

Thyroid Storm Further Rx

IV hydrocortisone 100 mgPTU 600 to 900 mg PO or NG, then 200 to

300 mg qidIodine (> 1 hour after PTU): 1 to 2 gm

sodium iodide IV drip, then 500 mg q 12 hr; or 20 gtts SSKI PO tid

+/- Li CO3 600 mg PO then 300 mg tid+/- Colestipol (binds T4 in gut) 10 grams

PO tid

Page 69: Endocrinemer.pre

Myxedema ComaRepresents end stage of improperly

treated, neglected, or undiagnosed primary hypothyroidism

Occurs in 0.1% or less of cases of hypothyroidism

Very rare under age 5050% of cases become evident after

hospital admissionMortality 100% untreated, 30 to 60%

treatedMost cases present in the winter

Page 70: Endocrinemer.pre

General Causes of Thyroid Failure

Diseases of the:–Thyroid (primary hypothyroidism) : 95 %–Pituitary (secondary hypothyroidism) : 4 %

ƒ Pituitary tumor or sarcoid infiltration–Hypothalamus (tertiary hypothyroidism) : < 1 %

Page 71: Endocrinemer.pre

Etiologies of Primary Hypothyroidism

Autoimmune : most commonPost thyroidectomyExternal radiationI 131 RxSevere prolonged iodine deficiencyAntithyroid drugs (including lithium)Inherited enzymatic defectIdiopathic

Page 72: Endocrinemer.pre

Symptoms of HypothyroidismCold intolerance DyspneaAnorexiaConstipationMenorrhagia or amenorrheaArthralgias / myalgiasFatigueDepressionIrritabilityDecreased attention +/- memoryParesthesias

Page 73: Endocrinemer.pre

Signs Related to Hypothyroidism

Dry, yellow (carotenemic) skinWeight gain (41% of cases)Thinning, coarse hair"Myxedema signs“ :

–Puffy eyelids –Hoarse voice–Dependent edema–Carpal tunnel syndrome

Anemia

Page 74: Endocrinemer.pre
Page 75: Endocrinemer.pre

Patient with myxedema coma

Page 76: Endocrinemer.pre

Hypothyroidism and Myxedema Coma Cardiac Signs

HypotensionBradycardiaPericardial effusionLow voltage EKGProlonged QTInverted or flattened T waves

Page 77: Endocrinemer.pre

EKG findings in a hypothyroid patient

Page 78: Endocrinemer.pre
Page 79: Endocrinemer.pre

Myxedema Coma Typical Presentation

Usual signs & sx of hypothyroidism plus:–Hypothermia (80 % of cases)

ƒ If temp. normal, consider infection present–Hypotension / bradycardia–Hypoventilation / resp. failure–Ileus–Depressed mental status / coma

Page 80: Endocrinemer.pre

Lab Studies to Order for Suspected Myxedema Coma

CBCLytes, BUN, glucose, calciumT3, T4, TSHSerum cortisolABGLFT's+/- drug levels

Page 81: Endocrinemer.pre

Precipitants of Myxedema Coma

Cold exposureInfection

–Pneumonia –UTI

TraumaCNS depressants

–Narcotics–Barbiturates–Tranquilizers–General anesthetics

CVACHF

Page 82: Endocrinemer.pre

Contributing Factors to Coma in Myxedema Coma

Hypothyroidism itselfHypercapniaHypoxiaHypothermiaHypotensionHypoglycemiaHyponatremiaDrug (sedative) side effect+/- sepsis

Page 83: Endocrinemer.pre

Emergency Treatment of Myxedema Coma

O2 +/- intubation / ventilation (if resp. failure)Rapid blood glucose check +/- IV D50 +/- NaloxoneHydrocortisone 100 to 250 mg IVPCautious slow rewarming (warm O2, scalp/groin/axilla warm

packs, NG lavage)Thyroxine (T4) 500 micrograms IV, then 50 mcg qd IVAdd 25 mcg triiodothyronine (T3) PO or by NG q 12h if T4 to

T3 peripheral conversion possibly impairedCareful IV fluid rehydration ; watch for CHFFollow TSH levels ; should decrease in 24 hrs. & normalize in

7 days of Rx

Page 84: Endocrinemer.pre

60 year old male with severe hypothyroid-ism

Page 85: Endocrinemer.pre

Same patient as on prior slide 6 months after Rx with T4

Page 86: Endocrinemer.pre
Page 87: Endocrinemer.pre

Causes of Hypoglycemia

Fasting–Insulinoma or extrapancreatic tumors–Extensive hepatic dysfunction–Starvation–Sepsis–Chronic renal failure–Glycogen storage diseases –Diseases with antibodies to insulin or receptor–Hormonal deficiency (steroids, growth hormone, epi)–Drugs (on next slide)

Postprandial (Alimentary, Reactive, Genetic - galactosemia or fructose intolerance)

Artifactual (leukemia, polycythemia)

Page 88: Endocrinemer.pre

Drugs Causing HypoglycemiaInsulinOral hypoglycemicsEthanolSalicylatesBeta blockersPentamidineDiisopyramideQuinineIsoniazidMAO inhibitorsVarious drugs causing decreased liver metabolism

of oral hypoglycemic agents

Page 89: Endocrinemer.pre

Symptoms and Signs of Hypoglycemia

Symptoms–Diaphoresis–Palpitations–Headache –Hunger–Trembling–Faintness

Signs–Hypothermia–Confusion–Amnesia–Seizures–Coma–ANY FOCAL CNS SIGN

Page 90: Endocrinemer.pre

Diagnostic Approach to Fasting Hypoglycemia

Prove that hypoglycemia is directly responsible for sx during attacks by showing:–typical sx–plasma glucose < 50 mg%–prompt relief of sx by glucose ingestion or IV

Consider checking:–Serum insulin level–Insulin antibodies–Sulfonylurea levels–C-peptide levels–Proinsulin levels

Page 91: Endocrinemer.pre

Causes of Polyuria

UTIOsmotic diuresis (e.g., diabetes mellitus)Primary (psychogenic) polydipsia

(Compulsive water drinking)Nephrogenic diabetes insipidusCentral diabetes insipidus

Page 92: Endocrinemer.pre

Causes of Diabetes Insipidus

Central–Head trauma–Craniopharyngioma–Infiltrative (sarcoid)–Post neurosurgery–Familial –Vascular–Infectious –Idiopathic

Nephrogenic–Drugs

ƒ Demeclocyclineƒ Lithium carbonate

–Acquiredƒ Sickle cell anemiaƒ K+ deficiencyƒ Hypercalcemiaƒ Amyloidosisƒ Sjogren Syndromeƒ Multiple myeloma

–Familial

Page 93: Endocrinemer.pre

Hormone Preparations for Rx of Diabetes Insipidus

Medication Duration of Action (hrs.)

Dose Route

Aqueous vasopressin

2 to 6 5 to 10 u SQ or IV

Lysine vasopressin

2 to 6 2 to 4 u Nasal

Pitressin in oil 24 to 48 5 u IM

Desmo- pressin

12 to 24 10 to 20 mcg

Nasal

HCTZ (for nephrogenic)

12 to 24 50 to 100 mg PO

Page 94: Endocrinemer.pre